The Dr. Donato Pérez García Clinic presents a range of integrative, functional, regenerative, metabolic, and immune-support treatments for patients with chronic, degenerative, and complex medical conditions. Its therapeutic model is centered on individualized medical assessment, multidisciplinary review, and the adaptation of each program to the patient’s diagnosis, medical history, general condition, previous treatments, and personal needs.

The treatments described below are based exclusively on the information published by the clinic. Their inclusion does not mean that every procedure is suitable for every patient. A medical evaluation is required before any therapy can be recommended or included in a treatment plan.

Insulin Potentiation Therapy (IPT/IPTLD)

Insulin Potentiation Therapy, also referred to as IPT or IPTLD, is one of the main procedures presented by the clinic. It is described as a specialized metabolic and bioregenerative treatment used within functional medicine.

The procedure uses fast-acting insulin as a biological response modifier. According to the clinic’s explanation, insulin is administered in a controlled clinical setting to temporarily increase the permeability of cell membranes. This process is intended to facilitate the movement of certain medications from the extracellular environment into the interior of the cells.

The therapeutic rationale described by the clinic is based on the idea that many diseases involve physical and chemical imbalances at the cellular level. When cellular structures and organelles are unable to perform their normal functions, symptoms and disease processes may develop. IPT is therefore presented as a method intended to support more targeted delivery of medications and promote correction of cellular dysfunction.

Objectives of IPT/IPTLD

• Temporarily increase cell membrane permeability under medical supervision.
• Facilitate the targeted entry of selected medications into cells.
• Support the use of lower medication doses in certain protocols.
• Seek to maintain therapeutic effectiveness while reducing the burden of side effects.
• Address disease processes from a metabolic and cellular perspective.
• Integrate medication delivery with nutritional, biological, and immune-support measures.

Conditions for Which the Clinic Describes IPT

The clinic states that IPT may be incorporated into individualized programs for chronic, degenerative, inflammatory, infectious, and oncological conditions. The published information specifically mentions:

• Breast cancer.
• Prostate cancer.
• Lung cancer.
• Colon cancer.
• Rheumatoid arthritis.
• Lupus.
• Osteoporosis.
• Chronic respiratory conditions.
• Chronic gastrointestinal conditions.
• Chronic infections.

The clinic presents IPT as an adjunctive or complementary approach. Its use, medication selection, frequency, duration, and relationship with conventional treatment must be determined individually by the medical team.

Integrative Cancer Support

The clinic describes an integrative oncology support program for patients with solid tumors and complex cancer cases. The purpose of this approach is not limited to targeting the tumor itself. It also considers the patient’s metabolic condition, immune response, nutritional status, tolerance to previous therapies, symptoms, and quality of life.

IPT/IPTLD may be included as a metabolic adjunctive treatment in these programs. According to the clinic, the intended goal is to improve targeted medication delivery while working to minimize treatment-related toxicity and side effects.

Elements That May Form Part of Integrative Cancer Care

• Individual review of the cancer diagnosis and clinical stage.
• Assessment of pathology reports, imaging studies, laboratory results, and previous treatments.
• Evaluation of the patient’s general condition and functional capacity.
• Metabolic support through IPT/IPTLD when considered medically appropriate.
• Immune-support procedures.
• Biological and cellular therapies.
• Intravenous therapies.
• Nutritional support programs.
• Monitoring of symptoms, tolerance, and treatment progress.
• Collaboration with specialists in oncology and other medical disciplines.

The clinic specifically mentions support for solid tumors involving the breast, prostate, lungs, and colon. It also states that it receives patients with advanced-stage or difficult-to-manage cases who are seeking a second opinion or complementary treatment options.

Dendritic Cell Therapy

Dendritic cell therapy is listed by the clinic as one of its cellular immunotherapy procedures. Dendritic cells are involved in the immune system’s ability to recognize and present antigens to other immune cells.

Within the clinic’s treatment model, this therapy is presented as a way to support the immune system’s recognition and response mechanisms. It may be considered as part of a personalized cancer-support program after review of the patient’s condition, previous therapies, laboratory findings, and treatment goals.

The clinic does not present dendritic cell therapy as a single universal protocol. Its inclusion depends on medical evaluation and may be combined with metabolic, nutritional, biological, or other immune-support treatments.

LAK-NK Cell Therapy

LAK-NK cell therapy is another immunotherapy approach identified by the clinic. LAK refers to lymphokine-activated killer cells, while NK refers to natural killer cells, which are components of the immune system involved in identifying and responding to abnormal cells.

The clinic presents this treatment as part of its experience in advanced cellular immunotherapy. The intended role is to support the patient’s immune response within a broader and individualized treatment plan.

Clinical Considerations

• Review of the patient’s diagnosis and current health condition.
• Assessment of immune status and relevant laboratory findings.
• Consideration of previous and ongoing cancer treatments.
• Evaluation of potential compatibility with other therapies.
• Continuous medical monitoring during the treatment process.

Natural Killer Cell Vaccine

The clinic lists an NK cell vaccine among its immune-based treatment options. Natural killer cells form part of the body’s innate immune defense and participate in the recognition of infected or abnormal cells.

Within the clinic’s integrative model, this procedure is intended to support immune activity as part of a personalized program. It may be considered alongside IPT/IPTLD, nutritional measures, intravenous therapies, and other biological procedures.

The suitability of this treatment must be determined through individual medical assessment. The clinic’s published information does not describe it as an automatic option for every patient or every type of cancer.

Treg Vaccine

The clinic also mentions a Treg vaccine, referring to a procedure associated with regulatory T cells. Regulatory T cells participate in the modulation and control of immune responses.

This procedure is presented within the clinic’s broader experience in immunotherapy and cellular medicine. Its role would depend on the patient’s condition, immune profile, diagnosis, and the therapeutic objectives established by the medical team.

Because immune regulation is complex, the clinic’s model emphasizes personalized assessment and clinical monitoring rather than applying the same protocol to all patients.

CAR-T-Related Procedures

CAR-T-related procedures are included among the cellular immunotherapy techniques referenced by the clinic. CAR-T therapy is associated with the modification or preparation of immune cells so that they can recognize specific targets.

The clinic presents its work in this area as part of its focus on advanced cellular immunotherapy and cancer-support innovation. The published page does not provide a complete technical protocol, eligibility criteria, manufacturing process, or indication list.

For this reason, any patient interested in CAR-T-related treatment would require a detailed case review to determine what type of procedure is being proposed, whether it is appropriate, and how it relates to other available medical options.

Exosome Therapy

Exosomes are listed by the clinic among its regenerative and cellular treatment options. Exosomes are small extracellular structures involved in communication between cells.

The clinic associates exosome-based procedures with regenerative medicine, immune support, and tissue-repair strategies. Their intended role is presented as supportive rather than as a standardized treatment for every condition.

Potential Areas of Use Within the Clinic’s Model

• Support of cellular communication.
• Regenerative medicine programs.
• Tissue-repair support.
• Immune-system support.
• Combination with other biological or metabolic therapies.

The specific source, preparation, administration method, number of sessions, and clinical goals must be explained to the patient during the medical evaluation.

Biological Medicine

Biological medicine is described as part of the clinic’s approach to chronic, degenerative, inflammatory, and immune-related conditions. It may be used alongside IPT/IPTLD, intravenous therapies, nutritional programs, and cellular procedures.

The objective of this approach is to consider the patient as a whole rather than focusing exclusively on a single symptom or diagnosis. Treatment planning may therefore include evaluation of immune function, inflammation, metabolism, nutrition, organ function, and recovery capacity.

Conditions Mentioned by the Clinic

• Rheumatoid arthritis.
• Lupus.
• Chronic infections.
• Respiratory diseases.
• Gastrointestinal diseases.
• Osteoporosis.
• Other chronic and degenerative conditions requiring individualized assessment.

Intravenous Therapies

Intravenous therapies are mentioned as part of the clinic’s comprehensive protocols for chronic conditions and integrative cancer support. These treatments allow selected substances to be administered directly into the bloodstream under medical supervision.

The clinic’s public information does not provide a fixed list of intravenous formulas. The composition, purpose, dosage, and number of sessions must therefore be established according to the patient’s diagnosis, laboratory results, nutritional condition, tolerance, and overall treatment plan.

Possible Therapeutic Purposes Within an Integrative Program

• Nutritional support.
• Metabolic support.
• Hydration and recovery support.
• Immune-system support.
• Complementary support during complex treatment programs.

Nutritional Programs

Nutritional support is described as one component of the clinic’s programs for chronic and degenerative conditions. It may also accompany metabolic and cancer-support therapies.

The nutritional plan is intended to be individualized according to the patient’s diagnosis, appetite, digestive tolerance, body composition, metabolic needs, laboratory findings, and treatment objectives.

Areas That May Be Considered

• General nutritional status.
• Ability to maintain weight and muscle mass.
• Digestive tolerance.
• Metabolic balance.
• Recovery needs.
• Compatibility with medications and other therapies.

Management of Chronic and Degenerative Conditions

The clinic presents comprehensive programs for patients with chronic and degenerative diseases. These programs may combine biological medicine, IPT/IPTLD, intravenous therapies, nutritional support, immune-support treatments, and continuous clinical monitoring.

The purpose is to evaluate not only the diagnosis but also the factors that may influence the patient’s symptoms, function, energy, inflammation, immune response, and quality of life.

Regenerative and Tissue-Repair Support

Regenerative medicine is one of the principal areas identified by the clinic. Its programs may include cellular therapies, exosomes, biological procedures, nutritional support, and other techniques intended to support tissue repair and functional recovery.

The selection of a regenerative procedure depends on the tissue involved, the patient’s diagnosis, age, general condition, previous treatments, and realistic therapeutic goals.

The clinic emphasizes that treatment should remain centered on safety, quality of life, and personalized medical supervision.

Supportive Care for Complex and Advanced Cases

The clinic states that it evaluates patients with complex conditions, including advanced-stage cases and patients seeking a second medical opinion. The approach is designed to provide supportive care while considering the patient’s symptoms, immune condition, metabolic state, treatment history, and personal preferences.

Possible Components of Supportive Care

• Review of the complete clinical record.
• Assessment of current symptoms and quality of life.
• Evaluation of previous treatment response and side effects.
• Metabolic and nutritional support.
• Immune-support procedures.
• Coordination with oncology, nephrology, cardiology, or other specialties.
• Monitoring of clinical progress and treatment tolerance.
• Discussion of realistic goals, limitations, risks, and alternatives.

How a Treatment Program Is Defined

The clinic presents its treatments as personalized programs rather than fixed packages. Before recommending a procedure, the medical team may review the patient’s diagnosis, pathology, imaging, laboratory studies, previous therapies, medications, allergies, organ function, symptoms, and general condition.

International patients may submit their clinical records and request an initial remote consultation. This preliminary review is intended to determine whether the case can be evaluated and which questions should be addressed before traveling or beginning treatment.

Typical Areas of Review

• Confirmed diagnosis.
• Current stage or severity of the condition.
• Previous and ongoing treatments.
• Current medications and supplements.
• Laboratory and imaging results.
• Cardiac, kidney, liver, and immune function.
• Nutritional and functional status.
• Potential risks and contraindications.
• Expected objectives and limitations of treatment.

Important Medical Information

The descriptions on this page summarize the treatments and therapeutic approaches presented by the Dr. Donato Pérez García Clinic on its official website. They do not constitute an independent evaluation of clinical effectiveness, regulatory status, safety, or suitability for a particular patient.

Some of the treatments described are complementary, integrative, regenerative, or cellular procedures that may not be considered standard care for every disease or in every country. Their risks, potential benefits, alternatives, costs, evidence, and relationship with conventional medical treatment should be reviewed carefully with qualified healthcare professionals.

No patient should discontinue, delay, replace, or modify a prescribed treatment without consulting the physician responsible for their care. Every procedure requires an individual medical assessment, explanation of risks and alternatives, and informed consent.